Almeida Micaela, Caeiro Vitor, Costa Diana, Silva Lara, Sousa Cíntia, Pestana Paula, Campelos Sofia, Vale João, Ramalhinho Ana Cristina, Fonseca-Moutinho José, Breitenfeld Luiza
Health Sciences Research Centre (CICS), Faculty of Health Sciences, University of Beira Interior (UBI), Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.
Department of Pathology, Ipatimup Diagnostics, Rua Júlio Amaral de Carvalho, 45, 4200-135 Porto, Portugal.
Pharmaceuticals (Basel). 2024 Sep 12;17(9):1201. doi: 10.3390/ph17091201.
Human papillomavirus (HPV), a leading cause of cervical cancer, is present in most cases of the disease and ranks as the fourth most common cancer in women globally. Among the HPV types, fourteen (HPV 16/18/31/33/35/39/45/51/52/56/58/59/66/68) are recognized as high-risk (hrHPV), each with varying levels of oncogenic potential. Detecting and genotyping these hrHPV types in cervical lesions is crucial, requiring the development of new diagnostic methods.
This study focuses on a retrospective analysis conducted on 44 women from the Cova da Beira Local Health Unit. We used the Anyplex™ II hrHPV Detection kit for hrHPV genotyping from paraffin-embedded cervical tissue samples.
hrHPV types were identified in 38 out of the 44 women. Genotyping revealed HPV-16 (55.3%), HPV-18/39/56/58/59 (5.3%), HPV-31 (21.1%), HPV-35 (7.9%), HPV-51/66 (2.6%), and HPV-52 (10.5%).
This study demonstrates that the Anyplex™ II hrHPV Detection kit, originally designed for cervical cancer screening, is also effective for hrHPV genotyping in histological analyses. This methodology offers a simpler and more cost-effective approach for cervical cancer risk stratification. Its implementation in clinical practice could enhance the detection of hrHPV in cervical lesions, thereby contributing to more precise diagnoses and potentially more informed treatment strategies.
人乳头瘤病毒(HPV)是宫颈癌的主要病因,在大多数宫颈癌病例中都有发现,是全球女性中第四大常见癌症。在HPV类型中,有十四种(HPV 16/18/31/33/35/39/45/51/52/56/58/59/66/68)被认为是高危型(hrHPV),每种都有不同程度的致癌潜力。在宫颈病变中检测这些hrHPV类型并进行基因分型至关重要,这需要开发新的诊断方法。
本研究聚焦于对贝拉地区科瓦当地卫生单位的44名女性进行的回顾性分析。我们使用Anyplex™ II hrHPV检测试剂盒对石蜡包埋的宫颈组织样本进行hrHPV基因分型。
44名女性中有38名检测出hrHPV类型。基因分型显示HPV - 16(55.3%)、HPV - 18/39/56/58/59(5.3%)、HPV - 31(21.1%)、HPV - 35(7.9%)、HPV - 51/66(2.6%)和HPV - 52(10.5%)。
本研究表明,最初设计用于宫颈癌筛查的Anyplex™ II hrHPV检测试剂盒在组织学分析中对hrHPV基因分型也有效。这种方法为宫颈癌风险分层提供了一种更简单、更具成本效益的方法。在临床实践中应用该方法可以提高宫颈病变中hrHPV的检测率,从而有助于更精确的诊断和可能更明智的治疗策略。